Floatz logo

Therapeutic Asset Ratings

416 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Arimidex
Neoplasm Metastasis
Eli Lilly and CompanyP4B (63)
LEUPROLIDE
Breast Neoplasms
Eli Lilly and CompanyP4B (63)
Ribociclib
Breast Neoplasms
Eli Lilly and CompanyP4B (63)
Carboplatin
Neoplasm Metastasis
Eli Lilly and CompanyP3B (63)
IMMUNOGLOBULIN G1, ANTI-(HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR TYPE VEGFR-2 EXTRACELLULAR DOMAIN) (HUMAN MONOCLONAL IMC-1121B .GAMMA.-CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL IMC-1121B .KAPPA.-CHAIN, DIMER
Advanced Cancer
Eli Lilly and CompanyP2B (63)
Donanemab
Brain Diseases
Eli Lilly and CompanyP3B (62)
Donanemab
Dementia
Eli Lilly and CompanyP3B (62)
Orforglipron
Chronic Kidney Disease
Eli Lilly and CompanyP3B (62)
Retatrutide
Osteoarthritis, Knee
Eli Lilly and CompanyP3B (62)
CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE
Neoplasm Metastasis
Eli Lilly and CompanyP3B (61)
Carboplatin
Uterine Cervical Neoplasms
Eli Lilly and CompanyP2B (61)
Irinotecan
Endometrial Neoplasms
Eli Lilly and CompanyP2B (61)
Irinotecan
Uterine Cervical Neoplasms
Eli Lilly and CompanyP2B (61)
Abemaciclib
Androgens
Eli Lilly and CompanyP3B (60)
Abemaciclib
Antineoplastic Agents
Eli Lilly and CompanyP3B (60)
Abemaciclib
Antineoplastic Agents, Hormonal
Eli Lilly and CompanyP3B (60)
Abemaciclib
Cyclin-Dependent Kinase 4
Eli Lilly and CompanyP3B (60)
Abemaciclib
Cyclin-Dependent Kinase 6
Eli Lilly and CompanyP3B (60)
Abemaciclib
Cytochrome P-450
Eli Lilly and CompanyP3B (60)
Abemaciclib
Enzyme Inhibitors
Eli Lilly and CompanyP3B (60)
Abemaciclib
Hormones
Eli Lilly and CompanyP3B (60)
Abemaciclib
Hormones, Hormone Substitutes, and Hormone Antagonists
Eli Lilly and CompanyP3B (60)
Abemaciclib
Physiological Effects of Drugs
Eli Lilly and CompanyP3B (60)
Abemaciclib
Prednisolone
Eli Lilly and CompanyP3B (60)
Abemaciclib
Prednisone
Eli Lilly and CompanyP3B (60)
Showing 51 to 75 of 416 assets
PreviousPage 3 of 17Next